Events Add an event Speakers Talks Collections
 

Speakers

Sort by
Newest
Trending
1-8 of 8
1-8 of 8
Filter
David Feldman
Attorney at Skip Intro Advisors
alternative medicine, anxiety, balance sheet, bank, brand, cannabis capital conference, cannabis community, cannabis consulting, cannabis funds, cannabis industry, cannabis investor presentation , cannabis market growth, cannabis sales, capital market, clinical trial, competition (economics), consultant, cost of capital, debt, drug, drug liberalization, drug overdose, earnings before interest, taxes, depreciation and amortization, equity (finance), finance, food and drug administration, goal, health, ibogaine, innovation, investment, investment banking, leadership, leaseback, lysergic acid diethylamide, major depressive disorder, market (economics), medication, mental disorder, motivation, n,n-dimethyltryptamine, opioid, perception, pharmacology, pricing, private equity, psilocybin, psychedelic drug, psychedelic science, psychiatry, psychology, psychotherapy, social stigma, stock dilution, substance use disorder, united states congress
Ankur Rungta
CEO and Co-Founder at C3 Industries
balance sheet, bank, brand, cannabis capital conference, cannabis community, cannabis consulting, cannabis funds, cannabis industry, cannabis investor presentation , cannabis market growth, cannabis sales, capital (economics), capital market, caregiver, competition (economics), consultant, consumption (economics), corporate finance, cost of capital, debt, demand, earnings before interest, taxes, depreciation and amortization, equity (finance), finance, goal, income, innovation, investment, investment banking, investor, kalamazoo, michigan, lawyer, leadership, leaseback, market (economics), mergers and acquisitions, michigan, new york city, option (finance), price, pricing, private equity, psychedelic science, retail, revenue, stock dilution, united states congress
John Leja
Founder, Board Member at NuSierra Holdings
agriculture, brand, cannabidiol, cannabis, concept, consumer confidence, convertible bond, cosmetics, crop rotation, crowdfunding, cultivator, debenture, debt, dietary supplement, discounting, farmers' market, financial capital, food and drug administration, hamburger, health claim, hemp, integrated pest management, interest, interest rate, investment, investor, maize, medical cannabis, mergers and acquisitions, mind, option (finance), organic certification, organic farming, pesticide, prescription drug, retail, soul, stock, stock dilution, tetrahydrocannabinol, traceability, valuation (finance), weed
Ryan McFarland
CEO at WhereZHemp
aphria (company), brand, cannabidiol, cannabinoid, cannabinol, cannabis, cannabis (drug), cannabis indica, chromatography, coffee, convertible bond, cosmetics, crowdfunding, debenture, debt, delta-8-tetrahydrocannabinol, dietary supplement, discounting, distribution (marketing), dose (biochemistry), drug enforcement administration, financial capital, flavor, food, food and drug administration, good manufacturing practice, health claim, hemp, instagram, interest, interest rate, investment, investor, kool-aid, license, linkedin, marketplace, medical cannabis, mergers and acquisitions, mountain dew, nestea, novel food, nutraceutical, option (finance), organic certification, pharmaceutical industry, pharmacy, prescription drug, pricing, qr code, recycling, retail, shelf life, soft drink, stock, stock dilution, target audience, tea, terpene, tetrahydrocannabinol, toast (honor), valuation (finance), youtube
Daniel Tobon
Chief Executive Officer / Director at iVIK Holdings Ltd
absorption (pharmacology), anti-inflammatory, anticoagulant, anticonvulsant, antidepressant, anxiolytic, benzodiazepine, brand, cannabidiol, cannabinoid, cannabinoid receptor type 2, cannabis (drug), certificate of analysis, clinical trial, convertible bond, cosmetics, crowdfunding, cytochrome p450, debenture, debt, democratic party (united states), dietary supplement, discounting, dose (biochemistry), drug interaction, drug overdose, entourage effect, financial capital, food and drug administration, geriatrics, gerrymandering, grapefruit–drug interactions, health claim, interest, interest rate, investment, investor, major depressive disorder, mechanism of action, medical cannabis, medication, mergers and acquisitions, neuroplasticity, neurotransmitter, opioid, option (finance), organic certification, over-the-counter drug, oxycodone/paracetamol, pharmacology, pharmacy, post-traumatic stress disorder, prescription drug, prothrombin time, psilocybin, psilocybin mushroom, psychedelic drug, pulmonary embolism, retail, sense, serotonin, signal transduction, stock, stock dilution, stroke, swing state, tetrahydrocannabinol, therapeutic index, valuation (finance), warfarin
Nathan Latka
Founder at SaaS Database GetLatka.com
analytics, bank, blog, book, brand, business, competition, cost of capital, credit, credit card, customer lifetime value, customer relationship management, debt, dividend, equity (finance), exponential function, fee, hashtag, hootsuite, interest, interest rate, internal rate of return, investor, job interview, lego, leverage (finance), linkedin, loan, lottery, market (economics), mortgage loan, onboarding, option (finance), oracle corporation, prepayment of loan, price, pricing, private equity, problem solving, revenue, revenue-based financing, seed money, small and medium-sized enterprises, startup company, stock, stock dilution, subscription business model, the wall street journal, twitter, upselling, use case, valuation (finance), venture capital, venture debt, virginia tech, virginia tech hokies football, wall street, warrant (finance), web conferencing
Peter Holzworth
Global Expansion Officer & Chief Revenue Officer at Green Horizon (CA) & Red Vault Extractions
alzheimer's disease, amazon (company), audit, barcode, behavior, bioavailability, brand, brand loyalty, candy, cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabinoid receptor type 2, cannabis, cannabis (drug), cannabis indica, cannabis sativa, cannabis strain, certification, chernobyl disaster, chinese cuisine, commodity, communication protocol, convertible bond, corporation, cosmetics, crowdfunding, debenture, debt, dietary supplement, discounting, discrimination, dose (biochemistry), drug test, due diligence, electronic cigarette, employment, entourage effect, farm-to-table, farmer, fda warning letter, federal food, drug, and cosmetic act, federal trade commission, financial capital, food and drug administration, food safety, fraud, generally recognized as safe, genetically modified food, globalization, gluten-free diet, good manufacturing practice, gummy candy, health claim, hemp, herbicide, hybrid (biology), industry, insomnia, insurance, intellectual property, interest, interest rate, investment, investor, kashrut, margin of error, medical cannabis, mergers and acquisitions, nsf international, nutraceutical, nutrition facts label, option (finance), organic certification, over-the-counter drug, pain, patent, pesticide, pharmaceutical industry, pharmacy, prescription drug, price, property, reason, regulation of food and dietary supplements by the u.s. food and drug administration, regulatory compliance, retail, risk management, sales, shampoo, sleep, social media, software , software patent, soil, solution, startup company, stock, stock dilution, supply chain, target corporation, target market, taste, tennessee, tetrahydrocannabinol, tobacco, trial, truck driver, valuation (finance), vitamin, walmart, warren buffett
Graciela Moreno
Director of Member Engagement at CBD Industry Association
alternative medicine, anti-inflammatory, appetite, audit, board certification, bong, brand, cancer, candida (fungus), cannabidiol, cannabinoid, cannabinoid receptor type 1, cannabis, cannabis (drug), cannabis indica, cannabis industry, cannabis sativa, central processing unit, chemotherapy, convertible bond, cosmetics, crowdfunding, debenture, debt, dietary supplement, discounting, dispensary, dose (biochemistry), dravet syndrome, education, emergency medical technician, endocannabinoid system, endocrinology, epilepsy, fda food safety modernization act, financial capital, food, food and drug administration, food safety, free market, good manufacturing practice, hair loss, health claim, hormone, interest, interest rate, investment, investor, iso 9000, kentucky, medical cannabis, medical school, medication, medicine, mental disorder, mental health, mergers and acquisitions, mind, nsf international, nursing, obesity, ondansetron, opiate, option (finance), organic certification, over-the-counter drug, paramedic, pathology, pediatrics, physician, prescription drug, probiotic, psychopharmacology, quality management system, regulatory compliance, research, retail, safety, schizophrenia, selective serotonin reuptake inhibitor, sleep, social stigma, specialty (medicine), stock, stock dilution, substance abuse, syndrome, synthetic cannabinoids, tetrahydrocannabinol, therapy, tony montana, traditional chinese medicine, valuation (finance), verification and validation, vitamin c, well-being
1
1-8 of 8